MPC Therapeutics
Biotechnology company focused on metabolism and rejuvenation
MPC Therapeutics has raised €1.5M across 1 funding round from 2 investors, most recently a Seed round in Jan 2023. Based in Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.5M
€1,513,928
Funding rounds
1
Investors
2
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearMPC Therapeutics — funding by year — interactive chart.
Data table
| MPC Therapeutics — funding by year | |
|---|---|
| 2023 | €1.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-10 | Seed | €1.5M | Angel Investors,Plutus Investment Group | View deal → |
Investors
2Angel InvestorsPlutus Investment Group
Related news
- CHF 1.5M for MPC Therapeutics Expanding Pipelinestartupticker.ch · 2023-01
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData